Evidence consistently demonstrated that redox-sensitive pathways-including NF-κB, NRF2, and IL-6/JAK/STAT3-drive colorectal carcinogenesis by promoting genomic instability, immune evasion, angiogenesis, and therapy resistance. The gene discussed is STAT3; the disease is medical procedure.